Matricelf
Highly Engaged Employees
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Golda Meir, Ness Ziona, IsraelPhone Number
+972 504057353Website
www.matricelf.comRevenue
<$5 MillionIndustry
About Matricelf
Matricelf Org Chart
Is Matricelf your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Matricelf has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Matricelf launches new products
Earning: See what the market has to say on Matricelf recently announced quarterly report
Click to see if Matricelf had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Matricelf
Funding: Get notified immidiatlly once Matricelf has new funding data
Matricelf, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Matricelf is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Matricelf is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Matricelf is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Matricelf.
Matricelf Tech Stack
A closer look at the technologies used by Matricelf
Matricelf News & Media
Matricelf Ltd. (TASE: MTLF) Reports Positive RNA Sequencing Results Demonstrating Promising Safety Profile of Its Personalized Spinal Cord Implant
NESS ZIONA, Israel, March 4, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered neural tissue implants for the treatment of spinal cord injury, today announced positive results from advanced RNA sequencing analyses of its...Matricelf Ltd. (TASE: MTLF) Signs MOU to Establish Subsidiary for Commercialization of Parkinson's Disease Therapy
NESS ZIONA, Israel, March 3, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced that it has signed a Memorandum of Understanding, subject to the execution of a definitive agreement and satisfaction...Matricelf Named Most Innovative Company of 2026 at Advanced Therapies Week in San Diego
Winner of the Innovation Exchange Award among 1,800 participants and 600 global drug developers; advancing toward first-in-human clinical study in spinal cord injury patients SAN DIEGO and NESS ZIONA, Israel, March 2, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology...Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
NESS ZIONA, Israel, Feb. 27, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced the appointment of Mr. Ron Mayron as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Matricelf
Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for a range of medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction et al. The company... Read More
